Unveiling HJURP as a Biomarker of Poor Prognosis and Immunotherapy Resistance in Lung Adenocarcinoma: A Multicenter Study
揭示HJURP作为肺腺癌预后不良和免疫治疗耐药的生物标志物:一项多中心研究
期刊:Clinical Medicine Insights-Oncology
影响因子:1.9
doi:10.1177/11795549251388872
Tan, Qinglin; Kong, Peiliang; Chen, Guobiao; Chen, Chen; Mo, Huiting; Huang, Yuancheng; Zhang, Manman; Cai, Yanmin; Zhang, Hanbin; Lu, Jianming; Wu, Yifen